4Pinzur M S. Diabetic peripheral neuropathy[J].Foot and ankle clinics,2011,(02):345. 被引量：1
5Hoffman DL,Sadosky A,Dukes EM. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy[J].{H}PAIN,2010,(02):194. 被引量：1
6Sharma U,Griesing T,Emir B. Time to onset of neuropathic pain reduction:a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia[J].{H}American Journal of Therapeutics,2010,(06):577-585. 被引量：1
7Schwartz S,Etropolski M,Shapiro D Y. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy:Results of a randomized-withdrawal,placebo-controlled trial[J].Current Medical Research & Opinion,2010,(01):151-162. 被引量：1
8Tesfaye S,Vileikyte L,Rayman G. Painful diabetic peripheral neuropathy:consensus recommendations on diagnosis,assessment and management[J].{H}Diabetes/Metabolism Research and Reviews,2011,(07):629-638. 被引量：1
